---
figid: PMC4568928__jcmm0019-2244-f1
figtitle: Proposed model for multiple-target inhibitory action in TT cells
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Diaporthe sclerotioides
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Drosophila melanogaster
pmcid: PMC4568928
filename: jcmm0019-2244-f1.jpg
figlink: /pmc/articles/PMC4568928/figure/fig01/
number: F1
caption: Proposed model for multiple-target inhibitory action in TT cells. This figure
  schematically shows the tyrosine kinase receptors, such as RET, VEGFR2, and some
  of their downstream effectors. The two most important oncogenic signalling pathways
  are PI3K/Akt/mTOR and Ras/Raf/MEK/ERK. Activation of these pathways may transduce
  different transcription factors and induce tumour cell proliferation, survival and
  migration, with subsequent tumour growth, lymphangiogenesis/angiogenesis, and metastasis.
  RAF265, SB590885 and ZSTK474 kinase inhibitors and their targets are shown too.
  Pathway map modified from SABiosciences.
papertitle: Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary
  thyroid cancer cells.
reftext: Loris Bertazza, et al. J Cell Mol Med. 2015 Sep;19(9):2244-2252.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9697778
figid_alias: PMC4568928__F1
figtype: Figure
redirect_from: /figures/PMC4568928__F1
ndex: a1c97a35-dec9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4568928__jcmm0019-2244-f1.html
  '@type': Dataset
  description: Proposed model for multiple-target inhibitory action in TT cells. This
    figure schematically shows the tyrosine kinase receptors, such as RET, VEGFR2,
    and some of their downstream effectors. The two most important oncogenic signalling
    pathways are PI3K/Akt/mTOR and Ras/Raf/MEK/ERK. Activation of these pathways may
    transduce different transcription factors and induce tumour cell proliferation,
    survival and migration, with subsequent tumour growth, lymphangiogenesis/angiogenesis,
    and metastasis. RAF265, SB590885 and ZSTK474 kinase inhibitors and their targets
    are shown too. Pathway map modified from SABiosciences.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Vegfa
  - Ret
  - Pik3r1
  - Pten
  - Src
  - Akt1
  - Akt2
  - Grb2
  - Shc1
  - Mtor
  - ras
  - Hras
  - Kras
  - Rem1
  - Braf
  - Braf-rs1
  - Mdk
  - Ephb2
  - Mapk1
  - Kdr
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - RET
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - PLCG1
  - PLCG2
  - SRC
  - FGR
  - FYN
  - YES1
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - MTOR
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - KDR
  - Pik3cg
  - Prkcg
  - Ephb1
  - lmd
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - reticulated
  - reti
  - rets
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - sl
  - Src42A
  - Csk
  - Src64B
  - Akt
  - drk
  - Sos
  - Shc
  - Tor
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - SB590885
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
